Literature DB >> 7679695

Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.

F L Ierino1, M D Hulett, I F McKenzie, P M Hogarth.   

Abstract

Fc gamma RII is a low affinity FcR for IgG with two Ig-like extracellular domains (D1 gamma and D2 gamma), a transmembrane domain, and a cytoplasmic domain. The production, characterization, and epitope analysis of four anti-human Fc gamma RII mAb (8.2, 8.7, 8.26, and 7.30) are detailed, and the mAb are compared with two defined CDw32 mAb, IV.3 and CIKM5. Reactivity of all mAb with Fc gamma RII was demonstrated by (a) specific binding to Fc gamma RII+ L cells (produced after transfection of L cells with human Fc gamma RIIa cDNA, HFc3.0), by using flow cytometry, (b) inhibition of the binding of SRBC sensitized with rabbit antibody (EA) to Fc gamma RII+ L cells, and (c) immunoprecipitation and SDS-PAGE, which detected a 42-kDa protein on K562 and U937 cells and a single 45-kDa protein on Fc gamma RII+ L cells. The mAb were able to detect different forms of Fc gamma RII, by flow cytometry, on Daudi cells (8.7 and 7.30) and U937 cells (8.2, IV.3, and CIKM5); 8.26 stained Daudi cells with intermediate fluorescence and U937 cells with the highest fluorescence, relative to the remaining mAb. Binding to transiently expressed isoforms of Fc gamma RII (a and b1) and four allelic variants of Fc gamma RIIa in COS-7 cells did not distinguish the mAb epitopes. Further mapping of the mAb epitopes was determined by (a) EA inhibition assays, (b) mAb blocking studies, and (c) the binding of the mAb to segments of human Fc gamma RIIa by using genetically engineered chimeric receptors. Chimeric receptors expressing either D1 gamma linked to domain 2 of Fc epsilon RI or domain 1 of Fc epsilon RI linked to D2 gamma were produced by exchanging homologous, but antigenically different, regions of Fc gamma RIIa and the high affinity receptor for IgE. Four clusters of mAb were identified, each mapping to discrete epitopes of Fc gamma RII. Cluster I (mAb 8.2 and CIKM5) defines a combinatorial epitope with determinants in D1 gamma and D2 gamma distant from the IgG Fc binding site, inasmuch as F(ab')2 fragments of 8.2 and CIKM5 do not inhibit the binding of EA to Fc gamma RII. The epitopes of clusters 2 (mAb 8.26), 3 (mAb IV.3), and 4 (mAb 8.7 and 7.30) are located entirely in D2 gamma and all involve the IgG Fc binding region, because F(ab')/F(ab')2 fragments of the mAb inhibit EA binding to Fc gamma RII. Thus, all mAb that inhibit the binding of EA map totally to D2 gamma; it is likely the IgG Fc binding region is also contained in D2 gamma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

2.  CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice.

Authors:  Todd Meyer; Liza Robles-Carrillo; Monica Davila; Meghan Brodie; Hina Desai; Mildred Rivera-Amaya; John L Francis; Ali Amirkhosravi
Journal:  Blood       Date:  2015-09-22       Impact factor: 22.113

3.  Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.

Authors:  Wei Zhao; Christopher L Kepley; Penelope A Morel; Lawrence M Okumoto; Yoshihiro Fukuoka; Lawrence B Schwartz
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

5.  Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.

Authors:  Paul A Ramsland; William Farrugia; Tessa M Bradford; Caroline Tan Sardjono; Sandra Esparon; Halina M Trist; Maree S Powell; Peck Szee Tan; Angela C Cendron; Bruce D Wines; Andrew M Scott; P Mark Hogarth
Journal:  J Immunol       Date:  2011-08-19       Impact factor: 5.422

6.  Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.

Authors:  Maria-Concetta Veri; Sergey Gorlatov; Hua Li; Steve Burke; Syd Johnson; Jeffrey Stavenhagen; Kathryn E Stein; Ezio Bonvini; Scott Koenig
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

7.  Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma).

Authors:  L F Pan; R A Kreisle; Y D Shi
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.

Authors:  Halina M Trist; Peck Szee Tan; Bruce D Wines; Paul A Ramsland; Eva Orlowski; Janine Stubbs; Elizabeth E Gardiner; Geoffrey A Pietersz; Stephen J Kent; Ivan Stratov; Dennis R Burton; P Mark Hogarth
Journal:  J Immunol       Date:  2013-12-16       Impact factor: 5.422

9.  Recombinant soluble Fc gamma RII inhibits immune complex precipitation.

Authors:  A L Gavin; B D Wines; M S Powell; P M Hogarth
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (Fc alpha RI) CD89.

Authors:  Richard J Pleass; Prabhjyot K Dehal; Melanie J Lewis; Jenny M Woof
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.